Tumour suppressor p53: understanding the molecular mechanisms inherent to cancer

被引:0
作者
Kumari, Rajni [1 ]
Sen, Nirmalya [1 ]
Das, Sanjeev [1 ]
机构
[1] Natl Inst Immunol, Mol Oncol Lab, New Delhi 110067, India
来源
CURRENT SCIENCE | 2014年 / 107卷 / 05期
关键词
Cancer; molecular mechanisms; stress signals; tumour suppressor genes; CELL-CYCLE ARREST; DNA-DAMAGE; GENE-EXPRESSION; IN-VITRO; P53-DEPENDENT APOPTOSIS; P53-INDUCIBLE REGULATOR; TRANSCRIPTION FACTOR; POTENTIAL MEDIATOR; REACTIVE OXYGEN; KINASE-ACTIVITY;
D O I
暂无
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tumour suppressor p53 has been the centre of focus of researchers trying to decipher the molecular mechanisms underlying tumourigenesis. In this review, we have summarized the critical role of p53 in tumour suppression through its effects on several cellular processes such as DNA repair, cell cycle and apoptosis. We have also discussed the role of upstream regulators which sensitize p53 to respond to different stress conditions. Post-translational modifications of p53 along with its binding partners have emerged as major determinants of its functional selectivity and specificity. Unravelling the intricacies of p53 functions have been augmented with the development of new mouse models of p53, which also have been discussed in this review.
引用
收藏
页码:786 / 794
页数:9
相关论文
共 106 条
[61]   THE P53 ACTIVATION DOMAIN BINDS THE TATA BOX-BINDING POLYPEPTIDE IN HOLO-TFIID, AND A NEIGHBORING P53 DOMAIN INHIBITS TRANSCRIPTION [J].
LIU, X ;
MILLER, CW ;
KOEFFLER, PH ;
BERK, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (06) :3291-3300
[62]   Apoptotic threshold is lowered by p53 transactivation of caspase-6 [J].
MacLachan, TK ;
El-Deiry, WS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (14) :9492-9497
[63]   Modeling the therapeutic efficacy of p53 restoration in tumors [J].
Martins, Carla P. ;
Brown-Swigart, Lamorna ;
Evan, Gerard I. .
CELL, 2006, 127 (07) :1323-1334
[64]   p53 regulates mitochondrial respiration [J].
Matoba, Satoaki ;
Kang, Ju-Gyeong ;
Patino, Willmar D. ;
Wragg, Andrew ;
Boehm, Manfred ;
Gavrilova, Oksana ;
Hurley, Paula J. ;
Bunz, Fred ;
Hwang, Paul M. .
SCIENCE, 2006, 312 (5780) :1650-1653
[65]  
MIYASHITA T, 1995, CELL, V80, P293
[66]   Apaf-1 is a transcriptional target for E2F and p53 [J].
Moroni, MC ;
Hickman, ES ;
Denchi, EL ;
Caprara, G ;
Colli, E ;
Cecconi, F ;
Müller, H ;
Helin, K .
NATURE CELL BIOLOGY, 2001, 3 (06) :552-558
[67]   miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities [J].
Mraz, M. ;
Malinova, K. ;
Kotaskova, J. ;
Pavlova, S. ;
Tichy, B. ;
Malcikova, J. ;
Kozubik, K. Stano ;
Smardova, J. ;
Brychtova, Y. ;
Doubek, M. ;
Trbusek, M. ;
Mayer, J. ;
Pospisilova, S. .
LEUKEMIA, 2009, 23 (06) :1159-1163
[68]   p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs [J].
Müller, M ;
Wilder, S ;
Bannasch, D ;
Israeli, D ;
Lehlbach, K ;
Li-Weber, M ;
Friedman, SL ;
Galle, PR ;
Stremmel, W ;
Oren, M ;
Krammer, PH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) :2033-2045
[69]   PUMA, a novel proapoptotic gene, is induced by p53 [J].
Nakano, K ;
Vousden, KH .
MOLECULAR CELL, 2001, 7 (03) :683-694
[70]   p53AlP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53 [J].
Oda, K ;
Arakawa, H ;
Tanaka, T ;
Matsuda, K ;
Tanikawa, C ;
Mori, T ;
Nishimori, H ;
Tamai, K ;
Tokino, T ;
Nakamura, Y ;
Taya, Y .
CELL, 2000, 102 (06) :849-862